In this special 35 minute edition of Genome Barks we hear from Dr. Jaime Modiano of the University of Minnesota.  Dr. Modiano discusses his CHF-funded research of hemangiosarcoma, as well as providing an overview on the progress being made in the field of hemangiosarcoma research.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks we hear from Dr. Bruce Smith of the Auburn University Research Initiative in Cancer (AURIC). The Auburn College of Veterinary Medicine recently received a $1 million appropriation from the state of Alabama for cancer research. Specifically, Dr. Smith discusses the focus of the "One Medicine" approach which links human, animal, and environmental health, and where discoveries in one species advance the health of all species.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this special edition of Genome Barks we hear from Dr. Shila Nordone, Chief Scientific Officer of the AKC Canine Health Foundation. May is Pet Cancer Awareness Month and throughout the month CHF will be highlighting currently-funded cancer research projects, providing information about different types of canine cancer, care for dogs with cancer, and other cancer-related health resources. In this podcast, Dr. Nordone provides an overview of the Foundation's commitment to canine cancer research, the future of canine cancer research and prevention, and the One Health / One Medicine approach to research which benefits not only dogs, but humans as well.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks we hear from Dr. Rondo Middleton of Nestlé Purina PetCare Company. Dr. Middleton discusses nutrigenomics, a field of study that measures how a nutrient or diet affects gene expression. Dr. Middleton shares the progress in the field, how studying nutrigenomics enables researchers to create diets that are healthier for dogs, and how these diets and nutrition plans can address specific symptoms of some canine health concerns.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks we hear from Dr. Bruce Hammerberg of North Carolina State University College of Veterinary Medicine. Dr. Hammerberg discusses allergy season, how it impacts dogs, common allergens, and treatments. Dr. Hammerberg also discusses his CHF-funded research that looks to develop a novel therapeutic drug for canine allergies.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of genome barks we hear from Dr. Betsy Sigmon, founder of Creature Comfort Veterinary Hospital, who discusses the signs and symptoms of heartworm disease. Additionally, Dr. Sigmon discusses the current treatment recommendations for this preventable disease.

To learn more about heartworm disease and to access the information shared in this podcast, visit:
http://www.heartwormsociety.org/pet-owner-resources/canine.html
animation of development of heartworms
http://www.capcvet.org/parasite-prevalence-maps/
search for heartworm incidence by state and county
http://www.cardiologycarenetwork.org/network/vet_FAQs.php#Group4 
questions and answers from NCSU college of vet medicine cardiology service

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks, Dr. Nick Duesbery, Co-Director of the Van Andel Research Institute’s Center for Comparative Biology and Genetics, discusses the Canine Hereditary Cancer Consortium (CHCC), a national alliance of researchers with a common hope of improving the health and welfare of humans afflicted with rare tumors, and canines affected with the same respective cancer. Dr. Duesbery credits a CHF research grant for helping set the groundwork for what eventually grew into the CHCC. CHCC researchers are unraveling the genetic causes of several cancers, including but not limited to: hemangiosarcoma, osteosarcoma, melanoma, malignant histiocytic sarcoma, and lymphoma.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks we hear from Dr. Snaevar Sigurdsson of the Broad Institute who discusses his research of genetic risk factors for osteosarcoma. Dr. Sigurdsson and his team are specifically looking at the Greyhound and other large breed dogs that have a higher incidence of osteosarcoma. After completing a genome-wide scan of the Greyhound, Dr. Sigurdsson and his team are now looking at the possibility of a tumor suppressive gene that may aid in better diagnosis and provide breeders with key genetic information.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks we hear from Dr. Roe Froman, a practicing veterinarian and a researcher at the Van Andel Institute in their Canine Hereditary Cancer Consortium (CHCC). Dr. Froman discusses the importance of testing and submitting DNA samples to organizations like the Canine Health Information Center (CHIC), and how dog owners and clubs can encourage sample collection from both healthy and affected dogs.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

In this edition of Genome Barks we hear from Dayna Dreger, a Ph. D. student at the University of Saskatchewan.  Dreger discusses agouti signaling proteins (ASIP) and how testing for agouti allels offers breeders / owners the opportunity to determine possible coat color outcomes from specific matings.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.